PAI-1 knockdown in paclitaxel-resistant cells also significantly reduces tumor growth in mice, suggesting a critical role for PAI-1 in maintaining paclitaxel resistance in breast cancer [224]. This evidence concerns the gene SERPINE1 and breast carcinoma.